As of year-end, $18.1 million of recurring billings for the period of April through December 2020 remain outstanding, of which $11.9 million have been reserved.
We are establishing 2021 operating FFO per share guidance of $0.77 to $0.87, which is an expected improvement over the annualized 2020 fourth quarter operating FFO per share of $0.72.
